Analysts think NNVC stock price could increase by 193%
Jul 30, 2024, 6:27 AM
-11.70%
What does NNVC do
NanoViricides, Inc., a development stage company based in Shelton, Connecticut, specializes in creating nanomedicine drugs targeting viruses, with leading candidates NV-CoV-2 and NV-CoV-2-R for COVID-19 treatment. Since its 2004 IPO, the firm has expanded its research to address various viral diseases, including RSV, herpes, and influenza types like H1N1 and H5N1.
3 analysts think NNVC stock price will increase by 192.72%. The current median analyst target is $6.63 compared to a current stock price of $2.27. The lowest analysts target is $6.57 and the highest analyst target is $6.83.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
